Comment on FDA clears blood test to aid evaluation for Alzheimer's diseaseparentComments−derekja18dMay not completely stop it, but lecanemab and donanemab are certainly considered to be disease-progression modifying at this point.
Comments
May not completely stop it, but lecanemab and donanemab are certainly considered to be disease-progression modifying at this point.